Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial

Andrew W Creamer*, Shaney L Barratt

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

9 Downloads (Pure)

Abstract

The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http://ow.ly/uHC030nEzsz.

Original languageEnglish
Pages (from-to)140-143
Number of pages4
JournalBreathe (Sheffield, England)
Volume15
Issue number2
DOIs
Publication statusPublished - 1 Jun 2019

Bibliographical note

Provisional acceptance date added, based on publication information,

Fingerprint Dive into the research topics of 'Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial'. Together they form a unique fingerprint.

Cite this